3320 — China Resources Pharmaceutical Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapSuper Stock

Annual balance sheet for China Resources Pharmaceutical, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	fx Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	47,067	46,522	32,231	25,648	27,913
Net Total Accounts Receivable
Net Total Receivables	62,772	67,872	102,607	110,327	114,834
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	143,903	152,259	178,568	185,846	201,707
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	20,804	22,092	25,376	26,339	32,845
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	202,531	215,534	246,770	257,760	285,811
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	115,151	121,770	134,233	132,222	142,209
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	160,991	171,977	200,811	209,516	234,403
Common Stock
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	41,540	43,557	45,960	48,244	51,408
Total Liabilities & Shareholders' Equity	202,531	215,534	246,770	257,760	285,811
Total Common Shares Outstanding